[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fTyI9XFjqR3Xxx_ZRKdWifDUXhnFQ5hq0K1Ib5dq54E4":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":33,"type":34},[],"2025-06-14 01:21:00",198511501,[8,9,10,11,12],"单相型躁狂症","单相型抑郁症","双相情感障碍目前为躁狂发作","双相情感障碍目前为抑郁发作","双相情感障碍目前为混合发作",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},42,"53e1d2ef4961cca8eea3e23969ad2cb9","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","默认课程","9d339aa89f1241e280b5fa62e0313101","第十一章 精神疾病的药物治疗","三环类抗抑郁药适用于",[22,35,45,55,65,75,85,95,102,112],{"answer":23,"createTime":24,"id":25,"options":26,"question":32,"source":33,"type":34},[],"2025-06-14 01:30:53",198511483,[27,28,29,30,31],"舒必利肌内注射","氟哌啶醇肌内注射","利培酮肌内注射","齐拉西酮肌内注射","帕利哌酮肌内注射","对以兴奋、激越为主要表现的精神分裂症患者宜首选","v1",0,{"answer":36,"createTime":5,"id":37,"options":38,"question":44,"source":33,"type":34},[],198511484,[39,40,41,42,43],"丙米嗪","氟西汀","舍曲林","米氮平","曲唑酮","若单用抗精神病药物不能完全改善精神分裂症伴有的抑郁症状时,可合并使用的抗抑郁药物宜首选",{"answer":46,"createTime":5,"id":47,"options":48,"question":54,"source":33,"type":34},[],198511485,[49,50,51,52,53],"奋乃静","氯氮平","奥氮平","利培酮","舒必利","以紧张症状群(木僵状态)为主的精神分裂症患者宜首选",{"answer":56,"createTime":57,"id":58,"options":59,"question":64,"source":33,"type":34},[],"2025-06-14 01:30:54",198511486,[60,61,62,29,63],"氯丙嗪皮下注射","氯丙嗪静脉注射","氯丙嗪肌内注射","利培酮静脉注射","对不合作的精神分裂症患者,宜选用",{"answer":66,"createTime":57,"id":67,"options":68,"question":74,"source":33,"type":34},[],198511487,[69,70,71,72,73],"4~6周","1~2周","2~3周","6~8周","3~4周","精神分裂症急性期疗程一般为",{"answer":76,"createTime":57,"id":77,"options":78,"question":84,"source":33,"type":34},[],198511488,[79,80,81,82,83],"急性肌张力障碍","帕金森综合征","恶性综合征","静坐不能","迟发性运动障碍","抗精神病药物少见但严重的不良反应是",{"answer":86,"createTime":5,"id":87,"options":88,"question":94,"source":33,"type":34},[],198511489,[89,90,91,92,93],"糖代谢障碍","蛋白质代谢障碍","脂代谢障碍","体重增加","催乳素分泌增加","抗精神病药物最常见和最主要的内分泌系统反应是",{"answer":96,"createTime":24,"id":97,"options":98,"question":101,"source":33,"type":34},[],198511490,[99,52,51,50,100],"齐拉西酮","阿立哌唑","粒细胞减少与缺乏发生率较高的是",{"answer":103,"createTime":24,"id":104,"options":105,"question":111,"source":33,"type":34},[],198511491,[106,107,108,109,110],"3周","1周","4周","5周","2周","应用SSRIs治疗的抑郁症患者若换用MAOls,SSRIs需停药",{"answer":113,"createTime":57,"id":114,"options":115,"question":116,"source":33,"type":34},[],198511493,[110,107,108,109,106],"应用MAOls治疗的抑郁症患者若换用SSRls,MAOls需停药"]